Related Experiment Video
Updated: Aug 20, 2026
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
Phage Display Technologies - SMi Conference. 23-24 January 2002, London, UK
1Cambridge Antibody Technology Group plc, The Science Park, Melbourn, Royston, Cambridgeshire, SG8 6JJ, UK. lutz.jermutus@cambridgeantibody.com
This fairly small meeting, with about 50 attendees, covered all areas of antibody engineering from basic technologies to applications in both therapeutic and diagnostic areas. Despite the fact that nearly all speakers came from commercial organizations, the data presented were solid and highly informative. While new technologies, such as yeast or ribosome display, are integrating into the drug discovery process, vaccine technology looks like a promising alternative to human antibody therapy. New advances in the field, especially in technology, are primarily governed by the tight intellectual property situation.
This fairly small meeting, with about 50 attendees, covered all areas of antibody engineering from basic technologies to applications in both therapeutic and diagnostic areas. Despite the fact that nearly all speakers came from commercial organizations, the data presented were solid and highly informative. While new technologies, such as yeast or ribosome display, are integrating into the drug discovery process, vaccine technology looks like a promising alternative to human antibody therapy. New advances in the field, especially in technology, are primarily governed by the tight intellectual property situation.
